Results 21 to 30 of about 108,706 (253)

AFP-L3 for the diagnosis of early hepatocellular carcinoma

open access: yesMedicine, 2021
Background: The present study aimed to systematically evaluate the diagnostic value of an isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a meta-analysis.
Jian-Ming Zhou, Ting Wang, Kun-He Zhang
semanticscholar   +1 more source

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

open access: yesFrontiers in Oncology, 2020
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is currently critical for improving the prognosis and reducing the associated economic burden.
Ting Wang, Kun-He Zhang
semanticscholar   +1 more source

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients

open access: yesBMC Cancer, 2021
Background Few biomarkers can predict the efficiency of PD-1 blockade in patients with hepatocellular carcinoma (HCC). This study aimed to investigate the prognostic role of AFP and PIVKA-II in HCC patients receiving anti-PD-1 immunotherapy.
Xuqi Sun   +8 more
semanticscholar   +1 more source

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma

open access: yesAnnals medicus, 2022
Background Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of scientific evaluation of relevant promising biomarkers as well.
Bing-yao Pang   +4 more
semanticscholar   +1 more source

AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway

open access: yesCell Death and Disease, 2020
Hepatocellular carcinoma (HCC) is a major leading cause of cancer-related death worldwide. Alpha fetoprotein (AFP) is reactivated in a majority of hepatocellular carcinoma (HCC) and associated with poor patient outcomes.
Tianke Chen   +15 more
semanticscholar   +1 more source

Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma

open access: yesBMC Cancer, 2021
Icaritin, an active ingredient of the Chinese herb Epimedium, plays an anti-tumor role in liver cancer by inhibiting the proliferation of hepatocellular cells and promoting their apoptosis.
Hui Li   +7 more
semanticscholar   +1 more source

Impact of Essential Oils (Orange Peels) on Ehrlich Ascites Carcinoma Against Cardiac Damage in Female Mice [PDF]

open access: yesJournal of Medical and Life Science
Cancer is defined as the accumulation of abnormal cells that are formed by cell proliferation and cause damage to all organs. According to reports from the World Health Organization, the number of people infected with this disease exceeds ten million ...
Ahmed Hasan   +4 more
doaj   +1 more source

Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19 [PDF]

open access: yesThe Ukrainian Biochemical Journal, 2022
Early diagnosis is very important to reduce morbidity and mortality in COVID-19 infected patients. The aim of this study was to detect of tumor antigens CEA, CA19.9, CA15.3, and AFP and to compare their levels in the serum of 69 COVID-19 patients and 69 ...
Abubaker H. Ali   +2 more
doaj   +1 more source

The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients

open access: yesDisease Markers, 2021
Background At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC) surveillance is insufficient. It remains controversial whether prothrombin induced by vitamin K absence II (PIVKA-II) has a better diagnostic ...
Fei Xu   +5 more
semanticscholar   +1 more source

Fondos de pensiones: Riesgo y rentabilidad; un análisis al caso chileno

open access: yesFórum Empresarial, 2004
En los últimos años las rentabilidades de los Fondos de Pensiones han bajado considerablemente, e incluso, en algunas oportunidades, éstas han sido negativas (en términos reales).
Carlos Díaz Contreras   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy